Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The polycomb group ring finger 3 pseudogene (LOC100420347, ENSG00000258836) is a genomic sequence derived from the Polycomb group ring finger 3 gene (PCGF3), lacking protein-coding capacity due to disruptive mutations or loss of regulatory regions[1][4]. While pseudogenes have been historically regarded as non-functional "junk DNA," recent studies show that some may produce noncoding RNAs involved in regulating their parent genes or other genes through diverse mechanisms such as microRNA decoy activity and gene silencing pathways[4][6]. There is no evidence that LOC100420347 produces a functional protein or is a direct drug target. Its biological impact, if any, is likely regulatory and indirect, possibly influencing gene expression in a cell- or tissue-dependent manner[4][5]. The parent PCGF3 gene encodes a component of Polycomb Repressive Complex 1 (PRC1), which is important for transcriptional repression in development and stem cell pluripotency, but the pseudogene variant does not share these canonical functions[9].\n\nIn summary, polycomb group ring finger 3 pseudogene is not a therapeutic target and is notable mainly as a noncoding regulatory element with possible indirect functions; all drug, biomarker, and safety entries are null. Its listing may be incorrect for most drug discovery or therapeutic contexts, as the functional protein-coding parent gene (PCGF3) would be the relevant entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polycomb group ring finger 3 pseudogene.